Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.

Item

http://www.wikidata.org/entity/Q38030981

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.

@en

type

Item

label

Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.

@en

prefLabel

Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.

@en

P1476

Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.

@en

P2093

Rik Schrijvers

http://www.w3.org/2001/XMLSchema#string

P2860

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

HIV-1 integrase inhibitor resistance and its clinical implications

Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)

Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

The HIV-1 integrase mutations Y143C/R are an alternative pathway for resistance to Raltegravir and impact the enzyme functions.

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.

P304

1969-1983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2012.712514

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zeger Debyser

P577

2012-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22849516

http://www.w3.org/2001/XMLSchema#string